Chris Stevens – Chief Executive Officer & Executive Director – Coda Minerals (ASX:COD) is an advanced exploration company primed to unlock the value of the highly prospective Elizabeth Creek Copper Cobalt Project in South Australia’s world class mining jurisdiction, the Gawler Craton.
Copyright 2024 – Finance News Network
Source: Finance News Network
10 Oct 2023 - Harry Fisher - Project Manager - Benchmark’s prices and data empowers clients: from critical mineral contracts to EV battery supply chain investments and government policy.
Read More09 Jan 2020 - IVE Group Limited (ASX:IGL) Executive Chairman, Geoff Selig, discusses the company's recent acquisition of Salmat Marketing Solutions and Reach Media New Zealand and its recent move to trading under the one IVE brand.
Read More27 May 2021 - Next Science Limited (ASX:NXS) Founder and Chief Technology Officer Dr Matthew Myntti talks about the problem of biofilms, Next Science's antimicrobial treatments and the company's recent FDA approval.
Read More22 Aug 2022 - archTIS Limited (ASX:AR9) CEO and Managing Director Daniel Lai discusses AR9's client base and growth plans, international markets, and collaborations with Microsoft and KPMG.
Read More27 Aug 2021 - LBT Innovations Limited (ASX:LBT) CEO and Managing Director Brent Barnes provides an update on sales and distribution for the company's Automated Plate Assessment System (APAS), which is used to read culture plates in laboratories.
Read More17 Nov 2022 - Genetic Signatures Limited (ASX:GSS) CEO and Director Dr John Melki discusses the company's technology, business model, 2022 highlights and outlook.
Read More21 Jul 2021 - icetana (ASX:ICE) CEO and Managing Director Matt Macfarlane provides an update for the June quarter 2021.
Read More03 Oct 2023 - Alex Hanly, CEO of Lithium Universe Limited (ASX:LU7), provides an update on the company's projects, discussing progress towards developing the Quebec Lithium Processing Hub.
Read More10 May 2022 - North Stawell Minerals Limited (ASX:NSM) CEO Russell Krause provides an update on the company, discussing recent drilling and outlook.
Read More28 Sep 2020 - Cyclopharm Limited (ASX:CYC) Managing Director and CEO James McBrayer provides an update on the company's US Phase 3 trial for Technegas, and USFDA approval process timeline, with commercial sales expected in the US for 2021.
Read More
